EP1307207A4 - EXTENDED TYPE 1 CHAIN GLYCOSPHINGOLIPIDS, USEFUL AS TUMOR ASSOCIATED ANTIGENS - Google Patents

EXTENDED TYPE 1 CHAIN GLYCOSPHINGOLIPIDS, USEFUL AS TUMOR ASSOCIATED ANTIGENS

Info

Publication number
EP1307207A4
EP1307207A4 EP00946971A EP00946971A EP1307207A4 EP 1307207 A4 EP1307207 A4 EP 1307207A4 EP 00946971 A EP00946971 A EP 00946971A EP 00946971 A EP00946971 A EP 00946971A EP 1307207 A4 EP1307207 A4 EP 1307207A4
Authority
EP
European Patent Office
Prior art keywords
tumor
associated antigens
extended type
glycosphingolipids
chain glycosphingolipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00946971A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1307207A1 (en
Inventor
Steven Levery
Sen-Itiroh Hakomori
Mark Stroud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomembrane Institute
Original Assignee
Biomembrane Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomembrane Institute filed Critical Biomembrane Institute
Publication of EP1307207A1 publication Critical patent/EP1307207A1/en
Publication of EP1307207A4 publication Critical patent/EP1307207A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
EP00946971A 2000-07-03 2000-07-03 EXTENDED TYPE 1 CHAIN GLYCOSPHINGOLIPIDS, USEFUL AS TUMOR ASSOCIATED ANTIGENS Withdrawn EP1307207A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/018219 WO2002002127A1 (en) 2000-07-03 2000-07-03 Extended type 1 chain glycosphingolipids as tumor-associated antigens

Publications (2)

Publication Number Publication Date
EP1307207A1 EP1307207A1 (en) 2003-05-07
EP1307207A4 true EP1307207A4 (en) 2005-12-14

Family

ID=21741553

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00946971A Withdrawn EP1307207A4 (en) 2000-07-03 2000-07-03 EXTENDED TYPE 1 CHAIN GLYCOSPHINGOLIPIDS, USEFUL AS TUMOR ASSOCIATED ANTIGENS

Country Status (6)

Country Link
EP (1) EP1307207A4 (enExample)
JP (1) JP2004502025A (enExample)
KR (1) KR100666238B1 (enExample)
CN (1) CN1291723C (enExample)
AU (2) AU2000260652B2 (enExample)
WO (1) WO2002002127A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5331293B2 (ja) * 2006-04-28 2013-10-30 公益財団法人野口研究所 多様性を表現するオリゴ糖またはその誘導体
KR101432474B1 (ko) * 2008-09-07 2014-08-21 글라이코넥스 인코포레이티드 항-연장된 ⅰ형 글라이코스핑고지질 항체, 이의 유도체 및 용도
CN104655859B (zh) * 2013-11-21 2017-10-03 苏州中赢医疗科技有限公司 乳腺癌的诊断标志物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992019634A1 (en) * 1991-05-06 1992-11-12 The Biomembrane Institute Extended type 1 chain glycosphingolipids as tumor-associated antigens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083929A (en) * 1991-05-06 2000-07-04 The Biomembrane Institute Extended type 1 chain glycosphingolipids as tumor-associated antigens

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992019634A1 (en) * 1991-05-06 1992-11-12 The Biomembrane Institute Extended type 1 chain glycosphingolipids as tumor-associated antigens

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0202127A1 *

Also Published As

Publication number Publication date
JP2004502025A (ja) 2004-01-22
CN1291723C (zh) 2006-12-27
AU2000260652B2 (en) 2005-10-27
EP1307207A1 (en) 2003-05-07
CN1460022A (zh) 2003-12-03
KR20030068120A (ko) 2003-08-19
WO2002002127A1 (en) 2002-01-10
AU6065200A (en) 2002-01-14
KR100666238B1 (ko) 2007-01-09

Similar Documents

Publication Publication Date Title
LU93106I2 (en) Property 180 sc
AU9447701A (en) Package
AU147391S (en) Packaging
IL151010A0 (en) Linezolid-crystal form ii
GB0024796D0 (en) Package
GB0014177D0 (en) Packaging
AU6065200A (en) Extended type 1 chain glycosphingolipids as tumor-associated antigens
GB9915419D0 (en) Antigens
AU144562S (en) Handleset packaging
GB0022441D0 (en) Cartons
PL112567U1 (en) Factory-protected package
GB0024548D0 (en) Packaging
GB0006475D0 (en) Packaging
GB0128848D0 (en) Packaging case
TW443370U (en) Improved form clasp
GB2365849B (en) Cartons
GB0017133D0 (en) Cartons
AU7426601A (en) Gene-regulating conjugates
PL338651A1 (en) Package
CA89059S (en) Package
CA89813S (en) Package
TW439825U (en) Improved form
GB0014574D0 (en) Packaging one
GB0008819D0 (en) Packaging
AU144049S (en) Packaging

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021220

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20051103

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61K 31/715 A

Ipc: 7C 08B 37/00 B

Ipc: 7C 07H 15/00 B

17Q First examination report despatched

Effective date: 20070921

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20101002